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Recent investigations have established that the thymus is essential for full 
development  of  immunologic responsiveness  in  mammals,  particularly  in 
rodents. The immunologic effects of neonatal thymic ablation have been par- 
ticularly well  characterized in  the mouse: atrophy of the  lymphoid tissues, 
depletion  of  lymphocytes in  the  peripheral  blood,  and  extremely deficient 
transplantation immunity permitting grafting of allogeneic and even xenogeneic 
tissues (1, 2). Antibody production is variably affected, depending apparently 
on the character of the antigen (1-6). The spleens and nodes of mice thymec- 
tomized as  newborns are  deficient in cells  capable  of exercising graft  versus 
host  activity  in  FI  hybrid  mice;  conversely,  neonatally  thymectomized F1 
hybrids are much more vulnerable to immunologic attack by injected parent 
strain cells (1, 2). The immunologic defect of these animals is almost invariably 
accompanied by a wasting syndrome, characterized by growth failure, physio- 
logic decline, and early death (1, 2). 
The immunologic deficit and growth failure  of neonatally thymectomized 
mice may be  prevented by several procedures performed during the  first  3 
weeks of life,  such  as  grafting  of newborn or  adult  syngeneic or  allogeneic 
thymus (7, 8), or injection of adult syngeneic spleen or lymph node cells (8-10). 
Partial reconstitution of cellular and immunologic characteristics may also be 
achieved by intraperitoneal implantation of millipore diffusion chambers con- 
taining thymic tissue, provided the graft is made early in life (11, 12). 
More recent studies have shown that restoration is possible with spleen cells 
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from donors differing from recipients at  minor  (non-H-2) histocompatibility 
loci (10),  and that immunologic reconstitution is also possible with syngeneic 
or allogeneic, adult or newborn thymus cells (6, 13). 
It  is  the  purpose  of  this  communication to  present comprehensive studies 
involving efforts  to  reconstitute  neonatally thymectomized mice  with  fully 
dispersed  cells from  syngeneic or  allogeneic spleen or  thymus,  extensions of 
earlier studies. Further, we will report attempts to reconstitute thymectomized 
mice with spleen grafts  from newborn or  older  donors of  the  same  or  other 
strains, and compare  their effectiveness with  that  of  thymic grafts.  Finally, 
extensions  of  preliminary efforts  to  reverse  the  wasting  process  when  it  is 
already established in neonatally thymectomized mice will be presented. These 
results show  that  the  wasting syndrome is regularly a  completely reversible 
process if the mice are  given enough thymus or spleen ceils which are  them- 
selves tolerated by the recipient host. 
Materials and Methods 
Mice.--Inbred mice  of the C3H/Bi, CE, CBA, A, and BALB/c strains, and (A X C57BL/ 
I)F1, (A X C3H)Fb (C3I-I X C57BL/1)F1, and (Call X DBA/2)F1 hybridswereused.  Mice of 
these strains were separated from the mouse colony of the late Dr. John ~[. Bittner in 1956, 
and have been maintained in our laboratories by rigorous inbreeding since that time. The de- 
tails of housing and care of the animals were given in an earlier paper (1). 
Surgical Procedures.--Thymectornies  were performed by the technique of Sjodin et al. (15). 
In sham operations, the thorax was opened but the thymus left intact. 
Thymus grafts were taken from newborn or older donors, sliced into three or four pieces, 
and introduced into the subcutaneous tissue of the back of the recipients. If the donor was 
newborn, the entire thymus was grafted; if older, an equivalent amount of thymus tissue was 
used. In other experiments splenic tissue was grafted in a similar manner; again, the entire 
spleen was used if the donor was newborn, and the equivalent of a newborn spleen (approxi- 
mately 10 to 25 mg of tissue) if the donor was an older animal. 
Skin grafts involved the placement of full thickness abdominal skin on a prepared site on 
the back of the recipient by the technique routinely employed in this laboratory  (16). The 
grafts are turned 180  ° for ease of identification. 
Cell Suspensions.--Suspensions  of cells from thymus or spleen were prepared in Ringer's 
lactate saline solution, using a glass Potter-Elvehjem homogenizer with a loose fitting pestle. 
Further dissociation of the cells was accomplished  by passing the suspension gently in and out 
of a 27 gauge and then a 30 gauge needle. Cell counts were made, and dilutions prepared so 
that 25 million nucleated cells were contained in 0.1 ml. Viability studies were performed using 
carmine and trypan blue staining; viability ranged upward from 90 per cent. All cell injections 
were intraperitoneal. 
Observa~Con.--All animals were observed at least every other day, and weights and clinical 
characteristics recorded. 
Graft Versus Host Assay of Sirnonsen (17).--This assay involves an assessment of the spleen 
enlargement in young F1 hybrid recipients of 30 million spleen cells from one of the parent 
strains injected intraperitoneally. Litters of 6 to 8, 8-day-old animals of an appropriate hybrid 
are divided into 3 groups of 2 or 3 mice each. At least 2 mice of each litter are prepared as: 
(a) experimental group, receiving cells from the animals whose immunologic competence is to 
be assessed; (b) negative controls, receiving syngeneic cells; and (c) positive controls, receiving E.  J.  YUNIS~ H.  R.  HILGARD~ C.  MARTINEZ~ R.  A.  GOOD  609 
cells from intact or sham-operated mice of the same strain as (a). Eight days after cell ad- 
ministration, the hybrids are sacrificed, their body and spleen weights determined, and the 
relative spleen weight (rag/100 gm body weight) calculated. Finally, the "spleen index" is de- 
termined by dividing the mean relative spleen weight of the experimental group by the mean 
relative spleen weight of the negative controls. 
Discriminating Assay of Cell  Chimerism.--This assay (18) was employed to ascertain the im- 
munogenetic composition of peripheral lymphoid tissues of mice grafted with ailogeneic  spleen 
or thymus, or treated with allogeneic spleen or thymus cells. As in the graft versus  host assay, 
spleen enlargement is assessed in young F1 hybrid recipients of cells from the presumed 
chimera, but different hybrids are used for host and donor components. Usually one parent 
strain of the two hybrids will be the same, a strain differing from both the host and donor 
strains at the H-2 histocompatibility locus. The other parent is donor or host strain depending 
on the component being assayed. The cell dosage is 30 million administered intraperitoneally. 
In this assay, the negative controls are prepared by administering to the F1 hybrid cells from 
the component of the chimera whichwill presumably be rejected by the hybrid, e.g. A cellsinto 
(car X C57BL/1)F1 hybrids. The positive controls are given cells from adult animals of the 
strain expected to be accepted by and react against the hybrid; e.g., A cells into (A X C57BL/ 
1)Fa. The relative spleen weights (rag/100 gln body weight) are determined at sacrifice of the 
hybrids 8 days later, and spleen indexes calculated. The experimental spleen index is calcu- 
lated by dividing the relative spleen weight of the experimental group by that of the negative 
controls. 
ttematology.--Total and differential white cell counts were performed on tail vein blood of 
8- to 10-week-old  experimental and control mice of the groups involved in reconstitution  ex- 
periments, and of 16- to 18-week-old  mice in the groups studied for reversal of wasting disease. 
These mice were kept under conditions in which the colony is light from 6 a.m. to 6 p.m., and 
dark from 6 p.m. to 6 a.m. Blood for lymphocyte counts was drawn between 9 a.m. and 12 
noon. 
Morphologie Stud/es.--Groups of mice were sacrificed at 90 to 100 days of age in the recon- 
stitution experiments and at 130 to 150 days of age in the reversal of wasting studies. The 
thymic area, spleen, axiilary lymph nodes, Peyer's patches, and fiver were fixed in 10 per cent 
formalin, cut, and stained as routine with hematoxylin and eosin. 
Autopsy.--In all neonatally thymectomized animals sacrificed for graft versus host assays 
or for morphologic study, the absence of mediastinal thymic tissue was verified under the dis- 
secting microscope and by microscopic examination  of  the mediastinal  contents.  In any 
animal bearing a thymus or spleen graft at sacrifice  or at death from wasting disease, the status 
of the graft was also ascertained. 
RESULTS 
Effect  of Administration of Fully Dispersed Syngeneic Thymus Calls to Neo- 
natally  Thymectomized  Mice.--Neonatally  thymectomized  CaI-I and A  strain 
mice were  injected intraperitoneally with either a  single dose  of  100  million 
syngeneic thymus cells or with 2 to 4 inocula of 50 million thymus cells each, 
as shown in Table I. The cell donors were newborn or 2 months old. Restora- 
tion was evaluated by body weight, survival to 120 days of age, and capacity 
of the recipient's spleen cells, at 6 to 9 weeks of age, to induce graft versus host 
reactions as assessed by the method of Simonsen (17). 
Text-figs.  1  and 2  indicate that  C~I-I and A  strain mice thymectomized at 
birth regularly showed  growth failure and succumbed between the 27th and 610  IMMUNOLOGIC  RECONSTITUTION  OF  TItYMIECTOMIZED MICE 
89th day of life. On the other hand,  the thymectomized mice receiving  syn- 
geneic thymus cells,  with few exceptions,  showed steady weight increase  and 
prolonged survival (Table I). 
Our prior studies, reported elsewhere  (13),  indicated that  the immunologic 
reactivity of neonatally thymectomized mice, as revealed by capacity to exer- 
cise graft versus host reactions,  could be restored by injections of 100 to 200 
million  syngeneic  thymus cells during the first 15 days of life. 
TABLE  I 
Survival of Neonatally Thymectomized Mice Treated with Fully Dispersed 
Syngeneic Thymus Cells 
Recipients 
Neonatally thymectomized C3H 
Neonatally thymectomized C3H 
Neonatally thymectomized C3H 
NeonataUy thymectomized C3H 
Intact C3H 
Neonatally thymectomized A 
Neonatally thymectomized A 
Intact A 
Age of cell 
donors 
mo~hs 
2 
2 
Newborn 
2 
Age of recipients 
at treatment 
days 
2,  7 
8,  11,  13,  15 
15 
5 
?otal 
to.  of 
t  ymus 
cells 
(1  illion) 
00 
:00 
00 
00 
SuIw~vors 
at 120 
days* 
6/10 
11/14~ 
7/9 
o/15§ 
19/20 
5/6 
0/12§ 
18/20 
* Most reconstituted animals surviving at 120 days were killed and examined for thymic 
remnants. 
:~ Four reconstituted survivors appeared normal when sacrificed at 14 months of age; no 
thymic remnants were found. 
§ All animals died  of wasting disease before 80 days of age. 
Thus,  it  may be concluded that  neonatally  thymectomized mice  may be 
almost completely restored,  with respect to growth, longevity, and immuno- 
logic capacity, by injection of sufficient  numbers of fully dispersed syngeneic 
thymus cells. Such reconstitution clearly does not require the structural integ- 
rity of the thymus itself. 
Effect of Administration  of Fully Dispersed Allogeneic Thymus Cells to Neo- 
natally Thymectomized Mice.--In these experiments (Table II), the neonatally 
thymectomized hosts were again of the A and CvI-I strains; the donors for the 
C3tt recipients were newborn or 2-month-old A or (A X  CvI-I)F1 animals,  or 
2-month-old  CBA mice.  To  distinguish  the  hybrid,  we have  used the  term 
"hemiallogeneic." The cell dosage varied from 100 to 400 million cells, and the 
criteria of reconstitution included growth, survival, and reactivity in the graft 
versus host assay. As a further test of immunologic  competence, cell-injected E..,T.  YUNIS~ H.  R.  HILGARD~ C.  MARTINEZ~ R.  A.  GOOD  611 
animals were grafted with skin from the cell donor strain as well as a  third 
aUogeneic strain. 
Text-fig.  2 and Table II document the growth and survival of the thymec- 
tomized A strain mice given CffI thymus cells. Most of these animals did not 
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T~cr-Fzo. 1. Growth curves of neonatally thymectomized CffI mice treated with newborn 
or adult syngeneic thymus cells, compared with those of intact Call mice and thymectomized 
mice given no further treatment. All the points on the curves are means; the numbers on the 
curves indicate the number of surviving animals at that age. All three forms of treatment 
averted the wasting disease.  It will be seen from the figure that neonatally  thymeetomized 
CsI-I mice given syngeneic thymus cells from  newborn  or  2-month-old donors  intraperi- 
toneally show  growth curves approaching those of normal Call  animals. Thymus cells ex- 
pressed in millions (M). 
develop wasting disease and survived to 120 days of age. By contrast, most of 
the thymectomized CffI mice treated with A strain adult or newborn thymus 
cells developed  an accelerated  wasting syndrome and died earlier  than most 
untreated neonatally thymectomized CffI animals. 
When neonatally thymectomized CffI mice were treated with thymus cells 
from adult or newborn (A X  CffI)F1 hybrid donors or from adult CBA donors 612  IMMUNOLOGIC  RECONSTITUTION  OF  THYMECTOMIZED MICE 
(a strain differing from the C~I strain at weak histocompatibility loci), they 
showed normal growth well beyond 90 days (Text-fig. 3) and survived to 120 
days of age and beyond (Table II). 
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TExT-FIO. 2. Growth curves of neonatally thymectomized A mice treated with syngeneic 
adult thymus cells, or with either adult or newborn CaI-I thymus cells, compared with those 
of intact mice and untreated neonatally thymectomized animals of the same strain.  All the 
points on the curves are means; the numbers on the curves indicate the number of surviving 
animals at that age.  All three treated groups maintained normal growth and had low mor- 
tality. Thymus ceils expressed in millions (M). 
Previous investigations (13) showed that the spleen cell population of thy- 
mectomized A strain mice, treated with 400 million C~-I adult thymus cells, 
was  of donor immunologic  type,  as evaluated by the discriminating spleen 
assay. Additional studies,  summarized in Table III, indicated that fully dis- 
persed newborn thymus cells also reconstituted the allogeneic hosts with respect 
to donor immunologic and histocompatibility characteristics. 
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treated with A strain newborn  or  adult thymus cells was  difficult to assess 
because most of the animals  died before 2 months of age, presumably from 
graft versus host reactions  induced by the A  strain thymocytes. However,  as 
shown in Table III, the discriminating spleen assays performed in the surviv- 
ing animals of these groups revealed  either no significant activity or activity 
of donor (A) histocompatibility characteristics. 
TABLE H 
Survival of Neonatally Thymectomized Mice Treated witk Fully Dispersed 
Allogeneix Thymus  :ells 
Recipients 
Neonatally thymectomized 
CaH 
Neonatally thymectomized 
C3H 
Neonatally thymectomized 
CsH 
Neonatally thymectomized 
CsH 
Neonatally thymectomized 
c~I 
Neonatally thymectomized 
A 
Neonatally thymectomized 
A 
Neonatally thymectomized 
A 
Thymus cell donors 
Strain 
A 
A 
(A X  CffI)F1 
(A X  C3H)F1 
CBA 
Call 
C3H 
CaH 
Age 
mo.a~ 
2 
New- 
born 
2 
New  ° 
born 
2 
2 
New- 
born 
New- 
born 
Age of recipient 
at treatment 
days 
15 
9 
5 
5,  8,  12,  15,  18, 
20,  22,  24 
10 
7,  12 
10 
5,  8,  12,  15,  28, 
20,  22,  24 
Total No, 
of Thy- 
mus Cells 
(million) 
300 
200 
200 
400 
200 
400 
200 
4OO 
Sur- 
vivors 
at 120 
days 
0/8* 
0/6* 
3/5 
12/125 
3/3 
8/85 
4/6 
9/20$ 
* These animals developed homologous disease and died before 50 days of age. 
5 Two mice from each group were sacrificed at approximately 200 days of age and had no 
thymic remnants. 
The results of allogeneic skin grafting on reconstituted animals were also of 
interest. Mice  of the  Call strain reconstituted with  (A  X  CsI-I)F1 or  CBA 
thymus cells accepted skin grafts from the cell donor strain or hybrid, but 
rejected skin from BALB/c donors. 
It can, thus, be concluded that hemiallogeneic thymus cells from either adult 
or newborn donors, and allogeneic thymus cells in certain donor-host combina- 
tions,  especially  those  involving  weak  histocompatibility differences,  may 
provide  full restoration  of  neonatally thymectomized mice  as  assessed  by 
growth, long-term survival, and immunologic function. In other strain combina- 
tions involving more rigorous immunologic barriers, as when A thymus cells are 614  ~LrNOLOGIC  RECONSTITUTION OF THYM-ECTOMIZED MICE 
given to C~-I mice, the thymus cells usually accelerate the growth failure and 
result in early death. Whenever immunologic restoration is provided by foreign 
thymus cells, the immunologic  and histocompatibility characteristics of the 
spleen cells of the reconstituted animals are those of the donor rather than the 
recipient strain. 
Thymect. C3H inj.  with thymocytes  (200 M) from 2- mos.- 
26-  old (AxC3H) FII mice.. 
24-  Thymect.  C3H inj,with thymocytes~J 
.  (400M)from  newborn  3/"  ~  .....  "  ....... 12 
(AxC3H) FII mice  /  X  "'""  ,3  22-  ."  ,"  /  ....-"  / 
g  /  /"  ,.J 
~  I 8  //  .."  /~-Thymect. C3H inj.  with 
5/  ,'""  J"  thymocytes(2OOM) 
o  i c 
"°~  16  m 2-mos.-old CBA m  e 
r'n 
]  ~  5  5~'~-Thymect.  C.~H inj.wirn 
,4  /~t  .......  3\ fhymOeyte~'(300  M  ) 
I/I/5  ~':  .....  %from  2-mos.-old A mice 
,Z/'//  .......  u,:., 
~t  5]~ymect.  C3W  ~. with thymocytes  (200 M) 
I  /2~  from  newt~rn A mice 
6/ 
,b  2'0  3'o  go  ~'o  ~  z'o  8b  9b 
Doys of Age 
T~.xT-FIO. 3. Growth curves of neonatally thymectom~,ed Ca[-I mice treated with newborn 
or adult, hemia]logeneic or aJlogeneic  thymus cells. All the points on the curves are means; the 
numbers on the curves indicate the number of surviving animals at that age. While treatment 
with  (A  X  CsH)FI and CBA thymus cells averted the wasting  syndrome in most of the 
animals, administration of either newborn or adult A cells resulted in an accelerated wasting 
disease in the neonatally thymectomized animals. Thymus cells expressed in millions (M). 
Effect of Administration of Syngeneic or Allogeneic Adult Spleen Cells to Neo- 
natally Thymectomized Mice.--In this series, attempts were made to reconstitute 
neonatally thymectomized CJ-I mice by intraperitoneal injection of 10 million 
spleen cells from 2-month-old syngeneic donors; 10 or 100 million spleen cells 
from allogeneic donors, differing at weak or strong histocompatibility loci from 
the recipients; and finally 10 or 100 million cells from hemiatlogeneic donors. 
Reconstitution was evaluated by growth, survival to 120 days, and the homo- 
graft response. 
The  results  of  these  experiments  are  shown  in Table  IV  and Text-fig.  4. 
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TABLE  HI 
Discriminating Spleen Assay of Neonatally  Tkymectomized Mice  Treated with 
Fully  Dispersed Allogeneic Thymus  Cells 
rhymec- 
tomlzed 
recipient 
strain 
C,H 
CmH 
Thymus cell donors 
--  --  Total 
No. of 
thymus 
.  __  [  cells* 
~traln  e.ge  (millions) 
mon~ks  I 
CsH  Newborn  400 
A  2  300 
A  Newborn  200 
Com- 
ponent 
asayed 
Donor 
Host 
Donor 
Host 
Donor 
Host 
Test litters 
(C~q  X C57BL/1)F1 
(A  X C57BL/I)F, 
(A X C57BL/I)Fx 
(Cd:I  X C57BL/1)Fx 
(A X C,57BL/1)F1 
(CsH X C57BL/1)F, 
Kan~e ot 
BnI~u 
m(lexes~ 
O. 87-2.1~ 
0.98-1.0; 
1.58 
1.00 
0.98--2.0~ 
0.86-1.1~ 
Mean 
spleen 
index 
1.59 
:  1.00 
i  i 
[  1.58 
i 1.00 
1.30 
1.03 
Number of 
Mice with 
significant 
graft ~orsus 
host 
activity 
(spleen 
index > 
1.30) 
3/4 
0/4 
1/1 
o/1 
1/s 
o/4 
* Thymus cells were injected intraperitoneally  during the first 4 weeks of life, as shown in Table IL 
Spleen indexes were calculated by dividing the relative spleen weight (rag/100 gm body weight) of the ex- 
perimental group by the relative spleen weight of the negative control group (syngeneic spleen cell injected ani- 
msls of the same hybrid). 
TABLE  IV 
Effect of Treatment with Adult Spleen Cells on Longevity and Skin Homograft Immunit~ 
of Neonatally Thymectomized  Mice 
Neonatally 
thymecto-  Spleen cell 
mlzed re-  donor strain 
C3H  C~-I 
Call  CBA 
Call  CBA 
C~H  CE 
C3H  CE 
C3H  (.4. X  C3H)Fz 
C3H  (A X  CsH)Fz 
CaH  A 
CaH  A 
A  C3H 
A  CaH 
No. of 
cells 
(million) 
10 
10 
100 
10 
100 
10 
100 
10 
100 
10 
I00 
Survivors 
at 120 
days* 
7/7 
4/6 
6/6 
6/7 
4/6 
7/8 
5/6 
o/11 
0/5 
5/6 
3/3 
Skin graft 
Late ot 
Donor strain  ~cept- 
~nce~ 
CBA  4/4§ 
CBA  5/5§ 
CE  6/6§ 
CE  4/4§ 
(A X  CsH)F1  6/6§ 
(A X  C3H)F1  5/5§ 
C~I-I  3/3 
Call  3/3 
Skin graft 
Donor  Rate  of 
strain  accept- 
ance:[; 
B~B/c  0/5 
BALB/c  0/4 
BALB/c  0/S 
BALB/c  0/6 
BALB/c  0/4 
BALB/c  0/6 
BALB/c  0IS 
BALB/c  1/311 
BALB/c  0/3 
* Most  reconstituted  survivors were  sacrificed  at  120  days  and  examined  for  thymic 
remnants. 
~: Number of mice accepting grafts for 30 days or more over the number grafted. 
§ Two mice from each group were sacrificed at about 200 days of age; no thymic remnants 
were found. 
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I-I-2  ~ but differing  at  weak histocompatibility loci)  gained  weight  normally 
(Text-fig. 4) and showed a large percentage of survivors at 120 days (Table IV). 
Similar  results were obtained when the spleen cell donors were  (A X  C3H)F1 
hybrid animals.  Skin  grafting studies confirmed  the immunologic  restoration 
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20  2-mos.-olddonors.  o-  ~  "~  ~  .,.t  ~  "~'" ~ .....  7 
/  ,/g/ 
.~  18'  C3H  neonatally thymect.  /  .,"V/ 
~.~  '  mice  inj.I.P,  with I0 to  ------/J'°'~--C3  H neonataJJy thymect. 
z=  ~6  ioo M  Ce spleen cells/':..'."  /  mice inj. I P with IO mi=l= 
.  from 2-mos.-old ,~,,,"  i"  C=H spleen cells from 2- 
donors.~  J'/"  ...~'  "~  >,  14'  t/.  mos.-old donors 
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TEXT-FZO. 4. Growth curves of neonataUy thymcctom~,ed CsH m~ce treated with adult 
spleen cells from syngeneic, hemiailogeneic, or ailogeneic donors. All the points on the curves 
axe means; the numbers on the curves indicate the number of surviving animals at that age. 
All the treatments were successful in averting wasting except injection of adult A strain spleen 
cells. Spleen ceils expressed in millions (M). 
of the animals: skin from the strain of the spleen cell donor was consistently 
accepted and skin from a third strain, BALB/c, regularly rejected (Table IV). 
On the other hand,  thymectomized C~-I mice treated with A strain spleen 
cells  (an  H-2  histocompatibility  difference)  failed  to  gain  weight  and  died 
before 65 days of age.  By contrast,  neonatally thymectomized A strain mice 
injected with 10 or 100 million adult CJ-I spleen ceils survived and were able 
to accept CvI-I skin grafts and to reject BALB/c skin. 
Effect of Syngeneic or Allogeneic Spleen Grafts on Neonatally  Thymectomized 
Mice.--In  the first series,  neonatally thymectomized C3H mice were grafted 
subcutaneously at 3 days of age with newborn spleen from A or C~-[ donors; E. ~. YUNIS~ H. R. HTr_,GA_-~ C. MARTINEZ~ R. A. GOOD  617 
27-  Thymect.  CsH grafted with spleen 
from I- mo.-old 
20- 
o 
A  18. 
E 
~  -  Thymect.  C~H grofted with 
16.  spleen  fror~ I-mo.-old A mice 
>, 14. 
~  - 
I0' 
8, 
6. 
4  ib  ~;o  z;o  ~  ~  ~  do  8o  9o 
Doys of Age 
T~xc-FIG. 5. Growth curves of neonatally  thymectomized C~T-I  mice grafted with newborn 
or adult, syngeneic or aIlogcneic spleen. All the points on the curves are means; the numbers 
on the curves indicate the number of surviving animals at that age. Only the grafting of 
syngeneic spleen from 1-month-o]d donors averted the wasting disease. By contrast,  spleen 
grafts from newborn syngeneic donors or from adult or newborn aJlogeneie  (A strain)  donors 
failed to prevent wasting disease. 
TABLE V 
Survival of Neonatally Thymectomised Mice Grafted wilh Syngenek or Allogenei¢ 
Spleen 
~ 
4 
8 
t~'~  J  Thymect.  A grafted with 
7  ,~,~xs  //spleen from I-mo.-old 
/  L./  -~'~  ~  C-,H mice 
I"  ° 
"LID':,'  "  7"  _  .. 
" i/  Thymect C_H grofled with 
13  f t~13 
6//~Thymect  O3H orofied wit5 spleen from newborn 
d  ~H mice 
Neonstally thymectomized  Spleen graft  Donor age  Recipient  age  Survivors at 
recipient strain  strain  at grafting  120 dsys 
C3I-I 
CsH 
C3H 
CsH 
A 
CsH 
CsH 
A 
A 
C3H 
mo~ks 
1 
Newborn 
1 
Newborn 
1 
Duy$ 
2 
2 
2 
2 
15 
4/5* 
o/6t 
o/st 
o/13I 
o/6t 
* Survivors were sacrificed at 120 days and examined for thymic remnants. 
All the mice in these groups died by 65 days of age; the spleen grafts were intact in all 
instances. 
in the  second,  thymectomized A  strain  mice  were  grafted  at  15  days  of age 
with spleen from 1-month-old C~I animals. 
The mean body weights  of these  groups of mice, illustrated  in Text-fig.  5, 
show that most of the animals grafted with either syngeneic newborn or allo- 618  IMMUNOLOGIC  RECONSTITUTION  OF  THYMECTOMIZED  MICE 
geneic  adult spleen tissue began to lose weight approximately 30 days after 
grafting and died by 65 days of age. On the other hand,  CJ-I mice thymecto- 
mized as newborns and grafted with spleen from 1-month-old  syngeneic  mice 
gained weight at a normal rate and survived (Table V). 
Figs. 1 to 6 illustrate spleen grafts recovered from neonatally thymectomized 
mice sacrificed at 6 weeks of age. The adtflt grafts (Figs.  1 to 3), which recon- 
stituted the syngeneic hosts, showed well developed lymphoid cells and typical 
lymphoid  organization.  However,  the  newborn  syngeneic  grafts,  composed 
primarily  of reticulum,  myeloid,  and  erythroid  cells  when  grafted  into  the 
thymectomized hosts at 3 days of age, remained immature organs and did not 
show lymphoid  maturation  51~  weeks after  placement  (Figs.  4  to  6).  The 
recipients of these newborn spleen grafts were not reconstituted. 
TABLE  VI 
Graft Versus Host Assay in (C3H X  DBA )F1 Hybrid Recipients of Spleen Cells 
from Neonatally Thymectomized Mice Grafted with Syngeneic Spleen 
Group 
Thymectomized C3H 
Thymectomized Call 
Intact Call 
Age Of spleen 
graft donor 
montks 
1 
Newborn 
Range of 
spleen indexes* 
1.91-2.52 
0.83-1.14 
2.19-3.52 
Mean 
splee~ 
index 
2.21 
0.97 
2.96 
No. of Mice with 
significant  graft vs. 
host activity (spleen 
index >  1.30) 
2/2 
0/3 
S/5 
* Spleen indexes were calculated by dividing the relative spleen weight (mg/100 gm body 
weight) of the experimental group by the relative spleen weight of the negative control group 
(syngeneic spleen cell-injected animals). 
Immunogenetic Analysis  of Spleen Cells of Spleen-Grafted Neonatally Thy- 
mectomized Mice.--These  studies were  undertaken  to ascertain  the immuno- 
logic activity in graft versus host reactions of host spleen cells from neonatally 
thymectomized C~-I mice  bearing syngeneic  spleen grafts,  and  the immuno- 
genetic  composition  of host  spleen  cells  from  allogeneic  (A)  spleen-bearing 
CnH animals.  These are different  groups from those discussed in the preceding 
section; however, the procedures were the same. 
The syngeneic  spleen-grafted animals  were sacrificed  at 5 to 8 weeks,  and 
suspensions  of  spleen  cells  prepared  for  injection  into  8-day-old  (C3H  X 
DBA/2)F1 hybrids.  Each  animal received 30 million  cells. Syngeneic  hybrid 
cells  were  administered  to the negative controls and  adult  C3H cells  to  the 
positive controls.  Splenomegaly was assessed 8 days later,  and spleen indexes 
calculated as shown in Table VI.  Adult  C3H spleen cells resulted  in spleen 
indexes of 2.00 or more, indicative of vigorous graft versus host activity. Simi- 
larly,  the  thymectomized  mice  grafted  in  the  newborn  period  with  adult E. 3. YUNIS~ H. R. HILGARD~  C. MARTINEZ~  R. A.  GOOD  619 
syngeneic spleen showed significant restoration of immunologic function by this 
criterion. By contrast, no restoration of graft versus host activity resulted from 
syngeneic newborn spleen grafts. 
In the groups of thymectomi~d C~I mice grafted with A strain spleen from 
newborn or 1-month-old donors,  the immunogenetic characteristics of cells of 
the host spleen were determined by the discriminating spleen assay, testing 
the host component in the (CsH X  C57BL/1)F1 hybrid and the donor compo- 
nent in the (A X  C57BL/1)FI hybrid. As shown in Table VII, there was no 
restoration of either donor or host reactivity when newborn spleen transplants 
were used. However, thymectomized  recipients of allogeneic spleen grafts from 
TABLE VII 
Discriminating  Spleen Assay of Neonat,  ally  Thyrnedomized Mice 
C-rafted with Allogeneic Spleen 
Recipient 
Thymectomized 
C~I 
Thymectomlzed 
CIH 
Spleen  graft 
donors 
S~ain  Age 
mont~ 
A  1 
A  Newborn 
Component 
assayed 
Cd~I  (host) 
A (donor) 
C~(host) 
A (donor) 
Test litters 
(CtH X  C57BL/I)F1 
(A X  C57BL/1)Ft 
(CtH X  C57BL/1)FI 
(A X  C57BL/1)Fx 
Range of 
spleen 
indexes* 
1.00-1.14 
1.91-2.01 
0.94--1.14 
0.97-1.03 
Mean 
spleen 
index 
1.07 
1.96 
1.03 
1.00 
No. Of 
Mice with 
significant 
graft vs 
host 
activiW 
(spleen 
index > 
1.30) 
o12 
2/2 
Ole 
0/6 
* Spleen indexes were calculated by dividing the relative spleen weight (rag/100 gm body weight) of the ex- 
perimentaf  group  by  the  relative  spleen  weight of  the  negative control  group  (syngeneic spleen  cell- 
injected animals). 
1-month-old donors  showed significant  immunologic reconstitution,  entirely 
attributable to donor immunogenetic characteristics. 
These results indicate that spleen grafts from syngeneic,  immunologically 
mature animals,  possessing mature lymphoid structure and organization,  will 
provide reconstitution of neonatally thymectomized mice. By contrast, spleen 
grafts from newborn (immunologicaUy immature) syngeneic donors, possessing 
little lymphoid tissue,  remain immature in the thymectomized recipient and 
do not provide reconstitution of immunologic function or of capacity to grow 
and survive under the conditions prevailing in the laboratory. When recon- 
stitution of neonatally thymectomized mice is achieved by allogeneic spleen 
transplants, the immunologic reconstitution is with respect to cells of the donor 
and not the host immunohistocompatibility characteristics. 
Reversal of Wasting Disease in Thymectomized Mice by Injection of Syngeneic 
Spleen  or  Thymus  Cell Suspensions.--In  these studies the administration of 620  IMMUNOLOGIC  RECONSTITUTION  OF  THYMECTOMIZED  M~ICE 
syngeneic spleen or thymus cells was withheld until the neonatally thymec- 
tomized C~-I recipients  had  developed  wasting disease. Body weights  were 
recorded every 3 days. Text-fig. 6 shows the body weight changes observed in 
15 C~-I mice thymectomized at birth; based on these data, the onset of wasting 
was considered to be the day of highest weight attained. 
The animals  selected for treatment had reached a maximum weight of at 
least l0 gm, followed by loss of 10 to 30 per cent of body weight, or by a failure 
of weight gain of at least 10  days' duration, and had other clinical signs of 
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Tv.xT-Fzo.  6. Individual weight curves of 15 neonatally thymectomized C3H mice, showing 
the variability in the physiologic decline of these animals, resulting in death of all the animals 
before 90 days of age. 
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wasting  disease. At this time, when the wasting animals  were 37  to 47 days 
old, each was injected intraperitoneally with 200 million syngeneic spleen or 
thymus cells. Reversal  of the wasting process was considered  to have been 
achieved if the treated mice showed a return to normal body growth and were 
healthy in appearance  60 days later. 
Eight of 9 spleen cell-treated mice began to gain weight 5 to 12 days after 
treatment and reached  the maximum pretreatment weight 6 to 20 days after 
cell administration. Each of these animals has continued to grow normally to 
the time of writing and is in good condition 1 year after treatment. Reversal 
of wasting disease was also observed in 3 of 10 thymus cell-injected animals 
(14). 
The immunologic capacity of spleen cells from some of these  animals  was V. ]. YUNIS, H. R. HILGARD,  C. MARTINEZ,  R. A. GOOD  021 
assessed by the graft versus host assay. The animals which recovered from the 
wasting disease were also restored immunologically, as judged by graft versus 
host activity in appropriate F1 hybrid animals (14). 
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TEXT-FIG. 7. Individual weight curves of 8 neonatally thymectomized Call mice injected 
with hemiallogeneic  (A X CsH)F1 spleen cells  after onset of the wasting syndrome.  The arrow 
indicates the time of cell injection in each instance. One animal died of wasting disease. Seven 
showed arrest of weight loss and return to normal weight gain; one of these died accidentally 
at about 90 days of age, and the others were alive and in good condition clinically  at 150 days 
when they were sacrificed.  None had thymus remnants. 
Reversal o.f Wasting Disease in Thymectomized Mice by Injection of Allogene@ 
Spleen Cells.--A and  C~-I mice were thymectomized as newborns,  and their 
weights recorded every 3 days. They reached their ma~mum weight, from 7.0 
to 17.2 gin, at ages ranging from 25 to 62 days. The allogeneic spleen cell dosage 
was  200  million  cells,  administered  when  the  animals  had  clinical  signs  of 
wasting and had either stopped gaining or lost weight. The time of treatment 
bore a variable relationship to peak weight, ranging from failure to gain for 1 TABLE VIII 
Immunologic  Reconstitution of Mice with Postthymectomy Wasting  Disease after 
Treatment with Allogeneic or Hemiallogeneic Spleen  Cells 
Neonat- 
any 
thymec- 
tomized 
recipients 
CIH 
C~H 
C~H 
CsH 
18 
16  ¸ 
Cell donor 
strain 
(A X  CsH)Ft 
CE 
CBA 
Treatment* 
200 X  10s  adult  spleen 
cells 
200 X  I0  s  adult  spleen 
cells 
200 X  10e  adult  spleen 
cells 
~urvivors 
120 days 
after 
treatment 
7/S§ 
4/~ 
2/3 
0/3111 
Skin graft 
Rate of 
Donor  accept- 
ance~ 
(A X  Call)F1  6/6 
CE  3/3 
CBA  2/2 
Skin graft 
Rate of 
Donor  accept- 
ance~ 
BALB/e  0/6 
BALB/c  0/3 
BALB/c  0/2 
* Cells were administered 5 to 20 days after onset of wasting. 
Number of animals accepting the graft for 30 days or more. 
§ One of the reconstituted survivors died accidentally 45 days after treatment. 
I[ All mice in this group died of wasting disease before 80 days of age. 
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Doys  of Age 
T~XT-FIo. 8. Individual weight curves of 6 neonatally thymectomized  A mice treated with 
200 million Call spleen cells after onset of wasting. The decline of the animals was not affected 
by the treatment, and all had died by 90 days of age. 
to 15 days, to loss of 5 to 28 per cent of peak body weight over periods of 5 to 
26 days. Again, the criterion of reversal was a return to normal weight gain and 
prolonged survival. 
Text-fig. 7 shows the reversal of wasting in CsI-I mice receiving spleen cells 
from 2-month-old (A X  Cv-I-I)F1  hybrid donors. Weight gain was restored, and 
most of the animals survived in good condition to 150 days of age. In additional E. J. YUNIS~ H. R. HILGARD~  C. MARTINEZ~  g. A. GOOD  623 
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Tx~r-lCxo. 9. Individual  weight curves of 5 neonatally  thymectomized C~I mice grafted 
with syngeneic newborn thymus after onset of wasting, as indicated by arrows. None of the 
animals showed clinical improvement; all died before 70 days of age. The thymus grafts were 
in good condition at the time of death. 
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TEXT-FIG. 10. Individual  weight curves of 5 neonatally  thymectomized C3H mice grafted 
with syngeneic adult  thymus after onset  of wasting,  as indicated  by arrows. None of the 
animals recovered, and all had died before 70 days of age. The thymus grafts were in good 
condition at the time of death. 
experiments,  we found that neonatally  thymectomized Cj-I mice which have 
already developed the wasting syndrome can be fully restored by injection of 
spleen cells from CBA or CE animals, strains differing from the C3H strain at 
minor  histocompatibility  loci.  The  survival  data  on  these  animals  are  sum- 
marized in Table  VIII. 
When neonatally thymectomized A  strain mice with overt signs of wasting 
disease  were treated with spleen cells from CsH donors (an H-2 histocompati- 
bility  difference),  the  wasting  disease  progressed  and  the  animals  died  early 
(Text-fig.  8). 624  IMMUNOLOGIC  RECONSTITUTION  O~'  THYM.ECTOMXZED  MICE 
Immunologic capacity of the  animals  that recovered from wasting  disease 
following hemiallogeneic or allogeneic spleen cell administration was tested by 
applying a  skin graft from a  third strain,  BALB/c, as shown in Table VIII• 
All these grafts were rejected, while grafts from the strain of the cell donors 
were accepted in all instances. 
These observations establish that the wasting disease of neonatally thymec- 
tomized mice, whatever its basis, may be reversed by treatment with syngeneic, 
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TExT-FIG. 11. Individual weight curves of 10 neonatally thymectomized  CaI-I mice, grafted 
at 38 days of age, with either A or CaH newborn thymus. Although none of the animals had 
clinical wasting disease at the time of grafting, all went on to develop  the typical runting and 
wasting syndrome, and died before 100 days of age with thymus grafts intact. 
allogeneic, or hemiallogeneic spleen cells.  Treatment of wasting animals  with 
allogeneic cells,  where donor and recipient differ at strong histocompatibility 
barriers, does not reverse the progressive growth failure or prolong life. 
Treatment of Postthymectomy Wasting Disease by Thymus Grafts.--The general 
experience, in  our own and  other laboratories,  has  been that  thymus grafts 
are of no benefit to mice that have already developed wasting disease. 
Text-figs. 9  and  10 show the  growth curves of neonatally thymectomized 
C~-I mice grafted with syngeneic newborn (Text-fig. 9) or 2-month-old (Text- 
fig. 10) thymus when signs of wasting were already present. These data reveal 
no significant weight gain when compared with control growth curves; clinically, 
the animals showed no other benefits from the grafts. All died early. E.  J. YUNIS,  H.  R. HILGARD,  C.  MARTINEZ,  R.  A.  GOOD  625 
In another group of C3H animals,  thymectomized as newborns, syngeneic or 
allogeneic (A) grafts were applied at 38 days, late in the prewasting period but 
before signs of the  disease  had appeared.  Text-fig.  11  illustrates  the  onset  of 
the wasting syndrome and the early death despite the thymic grafts. 
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TEXT-FIG. 12.  Lymphocyte levels of individual  CsH mice: normal,  thymectomized,  and 
reconstituted with hemiallogeneic thymus or spleen cells. All were 8 to 10 weeks of age at the 
time of assay. Also illustrated  is a comparison of lymphocyte counts of normal Call animals 
with those of two groups of animals whose wasting disease was reversed by administration  of 
spleen cells. The counts were done at 16 to 18 weeks of age when the animals were well clini- 
cally. The immunologic reconstitution  of all these groups was paralleled by the restoration of 
circulating lymphocyte levels to the normal range in most of the animals. 
The experience in both of these groups stands in striking contrast  with that 
of neonatally thymectomized C~I animals grafted at  7 days of age with new- 
born syngeneic or hemiallogeneic thymus. The latter  animals  did not develop 
wasting and survived normally. 
In all of these grafted animals,  the thymus tissue  was recovered at autopsy 626  IMMUNOLOGIC  RECONSTITUTION  OF  THYM.ECTOM-IZED  MICE 
TABLE  IX 
Reconstilution of Lymphoid Tissues of Neonatally Thymeaomized C3tt Mice 
Treated before and after the Onset of Wastin  Disease 
Treatment 
Spleen graft from C3H 4-week-old 
mice 
Spleen graft  from  C3H newborn 
mice 
100 X 10  s spleen cells from 8 to 10- 
week-old (A X  CaH)F1 mice 
200 X  l0  s thymus cells from 8 to 
10-week-old (A X CaH)F1 mice 
400 X l0  s thymus cells from new- 
born (A X C3H)F1 mice 
Reversal  of  wasting  200  X  106 
spleen cells from 8 to 10-week- 
old (A X  Call)F1 mice 
Reversal  of  wasting  200  X  106 
spleen cells from 8 to 10-week- 
old CE mice 
No treatment 
Tissue examined 
Spleen 
Lymph node 
Peyer's patch 
Spleen 
Lymph node 
Peyer's patch 
Spleen 
Lymph node 
Peyer's patch 
Spleen 
Lymph node 
Peyer's patch 
Spleen 
Lymph node 
Peyer's patch 
Spleen 
Lymph node 
Peyer's patch 
Spleen 
Lymph node 
Peyer's patch 
Spleen 
Lymph node 
Peyer's patch 
No. of Mice with lymphoid 
population 
No. of 
Mice 
3  1 
3  1 
3  1 
20  0 
20  0 
2O  0 
Moder-  [ 
ately  [ Markedly 
Nox  al  depleted  [  depleted 
I 
2  1  l  o 
1  1  1 
1  4 
0  1  1 
3  1  1 
1  2  1 
3  1  1 
0  2  1 
2  1  0 
1  1  1 
1  1  0 
1  2  0 
2  1  0 
2  2  1 
2  3  0 
1  3  1 
1  1 
2  0  +o 
5 
10 
]  1119 
and shown to be vascularized, normal appearing tissue, not significantly differ- 
ent from the curative grafts placed in younger animals before growth failure 
had occurred. 
Lymphocyte Counts.--Text-fig.  12 illustrates the absolute lymphocyte counts 
in the  peripheral blood of  8-  to  10-week-old experimental and control mice. 
Twenty-four of  25  normal C3H  mice had  absolute lymphocyte counts above 
2000  per  mm  3,  and  all  16  neonatally thymectomized  animals  of  the  same 
strain had counts below 2000 per mm  ~. Almost all of the mice protected from 
wasting  by  injection of  hemiallogeneic spleen  or  thymus  cells  had  counts E. J. ¥1TNIS,  H. R. HILGARD, C. MARTINEZ, R. A. GOOD  627 
above  2000 per mm  3,  as did the C,I-I animals  whose wasting disease was re- 
versed  by hemiallogeneic or allogeneic spleen cell administration. The counts 
of the latter groups were performed at 16 to 18 weeks of age. 
ttistologic Studies.--The histology of the spleen, lymph nodes, and Peyer's 
patches was evaluated in randomly selected animals of the several reconstituted 
groups at 90 to 100 days of age, except for the animals whose wasting disease 
was reversed by cell administration, sacrificed at 130 to 150 days. Comparable 
tissues were taken from long-term survivors  among the neonatally thymecto- 
mized animals not given further treatment, as well as from a group of animals 
unsuccessfully  treated with newborn  syngeneic spleen grafts.  In an effort to 
provide  objective  data, the lymphoid population of the tissues was classified, 
without knowledge of their source, as normal,  moderately depleted,  or mark- 
edly depleted.  The follicular structure was also assessed. 
In neonatally thymectomized CaI-I mice  the lymphoid tissues  show either 
marked or moderate depletion of lymphocytes, most extreme  in the Peyer's 
patches in our series and least so in the spleen, as shown in Table IX. The 
degree  of  deficiency  of follicular  structure  was  variable,  but  tended  to  be 
closely related to the deficiency in the total number of lymphoid cells present 
in the lymphoid tissue. 
Evidence of some degree of deficiency of total numbers of tissue  lympho- 
cytes  and  lack  of  normal  follicle  formation were  still  noted  in some  neo- 
natally  thymectomized mice  reconstituted  by  intraperitoneal  injection of 
spleen or thymus cells, or by subcutaneous spleen  grafts,  but in most of the 
animals these tissues showed evidence of restoration of varying degree (Table 
IX),  and some even had a  very normal morphologic  structure. In the neo- 
natally thymectomized animals grafted with newborn syngeneic spleen, there 
was no evidence of significant restoration of the lymphoid tissues. 
Figs. 7 to 14 illustrate the morphologic deficiencies of the peripheral lymphoid 
tissues of neonatally thymectomized  mice, and reflect the high degree of restora- 
tion of the morphology of these tissues achieved in some animals by administra- 
tion of thymus or spleen cells alone even in mice that had already developed 
the wasting syndrome before treatment was begun. 
DISCUSSION 
The observations  presented here are of interest from several points of view. 
First, we have shown  that procedures  which reestablish  the lymphoid cellu- 
larity of the  peripheral  lymphoid tissue  of  neonatally th~nectomized mice 
also reconstitute them immunologically and permit them to grow and develop 
normally. Procedures  found to be effective included intraperitoneal injection 
of adult or  newborn  thymus cells, or  of adult spleen  cells, from syngeneic, 
hemiallogeneic, and allogeneic donors; and early grafting of adult spleen or of 
adult or newborn thymus. 
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only if performed well before onset of the  wasting syndrome, while thymus 
and spleen cells restored older animals even those with well advanced wasting 
disease (8,  14). Since  thymus grafts apparently function, at least in part, by 
humoral, presumably hormonal, means (11, 12) these findings suggest that the 
spleen,  lymph nodes,  and  other  peripheral  tissues become refractory to  the 
effects of the hormone, perhaps as a result of failure of proliferation or death 
of potentially competent  lymphoid cells  seeded earlier  from the  thymus to 
the periphery, or because of loss,  in the absence of hormonal support,  of de- 
velopmental potential of reticular cells. 
By contrast, reconstitution with dispersed thymus or spleen cells permitted 
establishment in the peripheral lymphoid organs of an apparently self-sustain- 
ing population of lymphoid cells.  These were always of donor histocompati- 
bility characteristics when allogeneic donors were employed (8,  13,  14). The 
success  of "late" cell administration in preventing wasting and immunologic 
inadequacy, and particularly in reversing the  wasting syndrome when it is 
fully manifest, is  a  strong indication that  the essential defect in neonatally 
thymectomized mice is the deficiency of lymphoid cells in peripheral tissues. 
Certainly animals reconstituted in the present studies have  grown and sur- 
vived, in some instances for as long as 14 months, possessing normal or near 
normal immunologic vigor, in the complete absence of a thymus gland. 
If wasting disease is a consequence of infection or infestation, or of intoxica- 
tion from bacterial, viral or fungal flora, as recent studies with germ-free mice 
suggest,  (21,  22),  the infection or intoxication is preventable and even com- 
pletely reversible if the mice are given enough lymphoid cells from syngeneic, 
hemiallogeneic, or even allogeneic donors. It is important that the lymphoid 
cells administered be cells incapable of destructive graft versus host assault on 
the thymectomized host. If, as deVries et al.  (23, 24) have suggested, the runt- 
ing  and  wasting  of neonatally thymectomized mice is  a  consequence  of  an 
autoimmune process,  this destructive process is reversible simply by providing 
the neonatally thymectomized host with a  lymphoid cell population capable 
of repopulating the peripheral lymphoid organs. 
Of interest was  the finding that  adult spleen grafted into the  neonatally 
thymectomized lrdce  in very early life reconstituted  the  animals,  but  that 
newborn spleen did not. This confirms earlier findings that the newborn spleen 
in many mouse strains is primarily reticular, myelopoietic, and erythropoietic, 
and contains few lymphoid cells  (1);  and the  observation of Auerbach  (25) 
that  the  embryonic mouse  spleen is  incapable  of lymphoid development in 
vitro in the absence of thymus. 
Also  worthy of  attention is  the  contrast  in  the  results  of  reconstitution 
efforts in C~-I and A mice. Neonatally thymectomized A mice were regularly 
salvaged after injection of  C3H  newborn  or  adult thymus cells,  despite  the 
existence of an H-2 histocompatibility barrier between the strains. However, 
neonatally thymectomized C~-I mice were rarely saved from wasting disease E. J. YUNIS,  H. R. HILGARD,  C. ~ARTINEZ,  R. A. GOOD  629 
by injection of neonatal or adult A thymus cells. This suggests that,  even at 
birth, A strain thymus cells are capable of immunologic  assault on C3H tissues, 
while CaI-I thymus cells have relatively weak capacity to react against A strain 
recipients.  The results  of this reciprocal reconstitution experiment  may con- 
tribute to understanding of the relative ease of producing tolerance in neonatal 
CaI-I mice  using  A cells or antigens from A cells, and  the great difficulty  of 
producing immunologic  tolerance in newborn A mice with CJ-I cells or antigens 
(26 to 28). 
Our morphologic studies show, as have others (1, 2, 7, 9, 19), the deficiency 
of lymphocytes not  only in  the  peripheral  blood but in  the  lymph  nodes, 
spleen, and Peyer's patches of neonatally thymectomized mice. The restoration 
achieved by cell administration and spleen or thymus grafting has been illus- 
trated,  and is consistent with the concept expressed above, that the essential 
defect in neonatally thymectomized mice is underdeveloped peripheral lymph- 
oid tissue.  Infection, runting,  wasting, early death, immunologic  inadequacy, 
and  even  "autoimmune  processes"  sometimes  observed,  seem  to  us  to  be 
consequences of this inadequacy. 
Of potential clinical significance is the effectiveness  of late administration of 
thymus or spleen cells contrasted with the ineffectiveness of late thymus grafts. 
Consequently,  in  approaching  the  clinical  problems  of  the  thymus-based 
immunologic deficiencies,  such as the  Swiss type of agammaglobulinemia,  in 
which lymphopenia, immunologic  inadequacy, runting, and wasting seem to be 
attributable to a vestigial, underdeveloped thymic primordium (29 to 34),  or 
ataxia telangiectasia,  in which varying degrees of immunologic  deficiency are 
associated with incomplete lymphoid maturation of the thymus (35),  it may 
be fruitless to transplant thymus. Rather, we would predict from the observa- 
tions presented here,  that a more incisive approach would be to provide these 
patients  with  an  adequate  population  of  allogeneic  thymic  or  peripheral 
lymphoid cells, preferably matched to recipient  with respect to major histo- 
compatibility characteristics. 
S~r~M41~Y 
1.  Immunologic function,  growth,  and  longevity of neonatally  thymecto- 
mized mice was restored by intraperitoneal administration of 100 to 400 million 
syngeneic,  hemiallogeneic,  or allogeneic  thymus cells from newborn or adult 
donors.  Assays of the  graft  versus  host capabilities  of spleen cells from the 
animals  restored  with  allogeneic  cells  showed  that  their  immunologically 
competent cells are of donor histocompatibility characteristics.  Such animals 
accepted skin grafts from mice of the cell donor strain, but rejected skin from 
a third strain. 
2.  Similar results were obtained when the neonatally thymectomized animals 
were  treated  with  10  to  100 m/Ilion  syngeneic,  hemiallogeneic,  or allogeneic 
cells from adult spleen. 
3.  In one strain combination, CJ-I recipients  and A donors, injected thymus 630  IM~ILrNOLOGIC RECONSTITUTION OF THY~[ECTOMXZED MICE 
or spleen cells apparently attacked host  tissues,  since the  animals  died very 
early of wasting disease. When this combination was reversed, A  strain recip- 
ients treated with CaI-I cells were reconstituted immunologically and  physio- 
logically. 
4.  Syngeneic  or  allogeneic  adult  spleen,  grafted  in  the  newborn  period, 
reconstituted neonatally thymectomized mice,  but  all  experiments involving 
grafting of newborn spleen failed. Imrnunogenetic analysis of the host spleen 
cells  from  two  allogeneic  spleen-grafted  animals  previously  thymectomized 
showed that the reconstitution was entirely of donor histocompatibility char- 
acteristics. 
5.  Postthymectomy wasting disease was reversed by administration of 200 
million adult syngeneic spleen or thymus cells. Immunologic recovery was con- 
firmed by graft versus host assays of the spleens of the recovered animals and 
by application of allogeneic skin grafts. Some of the animals have been under 
observation for 42 weeks and appear to be normal. 
6.  The wasting  syndrome in  neonatally thymectomized mice  was  also  re- 
versed by injection of 200 million hemiallogeneic or allogeneic spleen cells. 
7.  Thymus grafts did not reverse wasting disease, whether the donors were 
adult or newborn, of the same strain or a different one. 
8.  Spleen, lymph node, and Peyer's patches from representative animals of 
the  reconstituted  groups  were  examined  and  compared  with  the  tissues  of 
untreated  neonatally  thymectomized mice  and  intact  animals  of  the  same 
strain. Tissues of normal cellularity and follicular organization were found in 
some  of  the  reconstituted  animals  and  also  in  mice  with  reversed  wasting 
disease. Extreme deficit of the lymphoid tissues was rare in either group. 
The authors are grateful for the assistance of Mr. Kenneth Sjodin who performed the 
thymectomies, and of Miss Dolores C. Breen who took the photomicrographs. 
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EXPLANATION OF PLATES 
PLATE 50 
FIG. 1.  Low power view of an adult  C~I-I spleen graft, implanted in a  neonatally 
thymectomized C~r-I recipient at 3 days of age, and recovered at 6 weeks. Such grafts 
maintained their structure and cellularity, and restored immunologic function in the 
recipients. Note the well developed lymphoid follicular structures (F) which make up 
a large part of the graft.  X  40. 
FI¢. 2.  Medium power view of part of a lymphoid follicle of the adult spleen graft 
in a  neonatally thymectomized C~I-I recipient.  Same tissue as shown in Fig.  1. Note 
that the follicular accumulation is made up of densely packed lymphocytes scattered 
among the stromal reticulum cells.  ×  400. 
FIG. 3.  High power view of portion of Fig. 1, showing the lymphocytic composition 
of the graft. Note that the cells are almost all large, medium, and small lymphocytes 
with uniform nuclear structure.  Few erythroblasts and myeloid cells are to be seen. 
The structure  and  composition of these adult  spleen grafts, which were capable of 
reconstituting  the  neonatally  thymectomized  mice,  is  very  similar  to  that  of  the 
spleens of normal mice; ×  1000 (oil immersion). THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  50 
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FIG. 4.  Low power view of a  newborn  C3H  spleen, grafted in  a  neonatally thy- 
mectomized C3H recipient at 3 days of age, and recovered at 6 weeks. It will be seen 
that  the graft did not develop lymphoid cells or follicular structure,  but was com- 
posed primarily of stromal-reticular tissue and frequent clusters of erythroid elements 
(E) and areas of myelopoiesis. Such grafts did not restore neonatally thymectomized 
recipients physiologically or immunologically.  ×  40. 
FIG. 5.  Medium power view of the neonatal spleen graft shown in Fig. 4. Note the 
clusters of erythroid-normoblastic cells (E), open areas composed primarily of reticu- 
lure cells (R), and megakaryocytes (MEG). X  400. 
FIG. 6.  High power view of a  portion of Fig. 4.  Note  the erythroid  (E) and my- 
eloid (M) elements and the very few lymphocytes (L). The striking differences in cel- 
lular composition of the spleen grafts shown here and in Fig. 3 are similar to the dif- 
ferences observed between spleens of newborn mice and  mice 2 to 3 months of age; 
×  1000 (oil immersion). THE  JOURNAL  Oil" EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  51 
(Yunis eta/. : Immunologic reconstitution of thymectomized mice) PLATE 52 
FIG. 7.  Spleen from a  neonatally thymectomized C~H mouse at 6  weeks  of  age. 
Although some lymphocytes are present, their number is so small that the spleen is 
lacking in characteristic organization and follicular arrangement. ×  100. 
FIG. 8.  Higher power view of  the  follicular region of  a  depleted neonatally thy- 
mectomized mouse spleen. The sparsity of lymphocytes and the abundance of reticu- 
lum cells are evident. Follicular centers are to be found but they contain few lympho- 
cytes.  ×  400. 
FIG. 9.  The spleen of  a  3-month-old C~H  mouse thymectomized in the neonatal 
period and reconstituted by the intraperitoneal injection of 100 million (A  ×  C3H)F1 
"hemiallogeneic" spleen  cells.  Note  the  abundance of  lymphocytes and  the  well 
developed follicular organization (F).  ×  100. 
FIG. 10.  Higher power view of a splenic follicle in the spleen illustrated in Fig. 9. 
Note  the  abundance of  small lymphocytes in this region.  Reticulum stroma  is,  of 
course, present as in Fig. 8, but the greater  concentration of lymphocytes tends to 
obscure this component. X 400. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  52 
(Yunis et al. : Immunologic  reconstitution of thymectomized mice) PLATE 53 
FIG. 11.  Low power view of an axillary lymph node of a  6-week-old Call mouse 
that  had  been  thymectomized at  birth.  The  lack of  follicle development and  the 
relative sparsity of small lymphocytes are apparent.  X  40. 
FIG. 12.  Low power view of the axillary lymph node of a  120-day-old neonatally 
thymectomized Call mouse whose wasting disease was reversed by injection of 200 
million CE  spleen  cells  (weak  histocompatibility barrier).  The  follicular structure 
and  lymphocyte numbers  approach  those  of  normal lymph  nodes.  Note  the  thick 
collars of small lymphocytes surrounding the well developed follicles in the cortex of 
this node.  X  40. 
FIG, 13.  Higher power view of  the  lymph  node  illustrated in  Fig.  I I.  Note  the 
relative deficiency of small lymphocytes and the relative abundance of larger lymphoid 
cells and reticulum cells. X  250. 
FIG. 14.  Higher power view of the lymph node illustrated in Fig. 12. Note the well 
developed collar of small lymphocytes in the neonatally thymectomized mouse whose 
wasting  disease was  reversed by intraperitoneal injection of  200  million allogeneic 
spleen cells. X  250. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  53 
(Yunis et al. : Immunologic reconstitution of thymectomized mice) 